XBIT
XBiotechCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
Composite grade C from latest DB weights. Momentum 37.9 / Value 57.6
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.6.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
38
Value
58
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Why
Momentum38 · Δ7d -
Value58 · Δ7d +0.6
SentimentN/A · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
38
40% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
58
60% active weight
Current posture
7d trendFlat
Δ7d
+0.6
Δ21d
+0.5
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 37.9 / Value 57.6
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$68.6M
Beta
0.86
Shares Out
30.49M
P/E (TTM) · Derived
-1.5
P/S (TTM)
-
P/FCF (TTM) · Derived
-1.62
Rev YoY
-100.0%
EPS YoY
-49.4%
Gross Margin
-489.7%
Op Margin
-
Net Debt
-$125.55M
Current Ratio
39.03
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology